Largest Taiwanese (TAIEX) Pharmaceuticals & Biotech Stocks by Market Cap

UPDATED Sep 25, 2025

Discover large cap Taiwanese Pharmaceuticals & Biotech companies that are on the TAIEX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

134 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
6919
Caliway Biopharmaceuticals
NT$184.501.4%211.1%NT$286.2bNT$245.00PS6383xE199.6%n/a
6446
PharmaEssentia
NT$512.000.2%-10.1%NT$189.4bNT$592.01PE46.7xE70.2%0.2%
6472
Bora Pharmaceuticals
NT$680.00-1.4%7.8%NT$84.4bNT$847.46PE16.5xE8.3%1.7%
1795
Lotus Pharmaceutical
NT$255.0034.6%-5.6%NT$67.1bNT$378.20PE13.8xE28.6%2.2%
6535
Lumosa Therapeutics
NT$286.00-8.3%-11.0%NT$48.2bNT$360.00PS1293.4xS-3.7%n/a
4743
Oneness Biotech
NT$67.20-0.7%-52.5%NT$32.1bNT$308.00PS285.5xn/a0%
6550
Polaris Group
NT$37.100%-32.3%NT$28.6bn/aPS446.5xn/an/a
4123
Center Laboratories
NT$38.85-1.6%-20.7%NT$27.6bn/aPS17.3xn/a1.9%
6949
Pell Bio-Med Technology
NT$402.00-8.5%396.3%NT$23.4bn/aPS854.5xn/an/a
4728
Sunmax Biotechnology
NT$404.00-2.8%54.2%NT$22.0bn/aPE31.5xn/a2.9%
4147
TaiMed Biologics
NT$76.20-1.0%-4.9%NT$20.8bNT$161.00PS34.8xn/an/a
6589
EirGenix
NT$66.7011.2%-23.9%NT$20.2bNT$138.00PS21.1xn/an/a
4105
TTY Biopharm
NT$77.701.7%5.0%NT$19.3bNT$81.00PE12.2xn/a5.4%
6620
Handa Pharmaceuticals
NT$118.004.0%71.8%NT$18.5bNT$200.00PE29.8xn/a1.3%
6712
Ever Supreme Bio Technology
NT$178.508.8%5.6%NT$15.6bNT$210.00PE38.3xE18.2%2.6%
4114
Synmosa Biopharma
NT$34.10-2.3%0.5%NT$15.5bNT$37.00PE21.4xn/a1.6%
3705
YungShin Global Holding
NT$57.402.5%-8.5%NT$15.3bn/aPE15.5xn/a5.2%
1789
ScinoPharm Taiwan
NT$18.902.7%-25.7%NT$14.9bNT$18.00PE73xE31.4%1.9%
6785
Alar Pharmaceuticals
NT$213.500.9%14.8%NT$14.3bn/aPS2017.2xn/a0.1%
6696
Lin BioScience
NT$160.50-1.8%73.7%NT$13.3bn/aPB4.7xn/an/a
6576
Foresee Pharmaceuticals
NT$82.500.1%0.1%NT$12.8bNT$126.50PS28.9xn/an/a
6547
Medigen Vaccine Biologics
NT$38.30-2.5%-15.5%NT$12.6bNT$102.00PS19.9xn/an/a
6541
Tanvex BioPharma
NT$51.804.1%-25.5%NT$12.4bn/aPS111.4xn/an/a
6617
Gongwin Biopharm Holdings
NT$99.40-4.4%-15.0%NT$12.2bn/aPS353.6xn/an/a
Page 1 of 6